Published in Int J Lepr Other Mycobact Dis on November 06, 1970
Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis (1966) 22.28
Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med (1971) 11.44
Further observations on the formol-ether concentration technique for faecal parasites. J Clin Pathol (1970) 6.50
Ultrastructural study of the behavior of macrophages toward parasitic mycobacteria. Infect Immun (1972) 5.12
Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J Exp Med (1975) 4.73
The compromised host and infection. II. Deep fungal infection. J Infect Dis (1969) 4.63
BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br Med J (1977) 4.48
Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy. Clin Exp Immunol (1973) 4.12
Inhibition of haemaggregation by lepromin and other mycobacterial substances. Nature (1967) 3.84
Lymphocyte-mediated modification of blood-derived macrophage function in vitro; inhibition of growth of intracellular mycobacteria with lymphokines. Clin Exp Immunol (1971) 3.74
Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon. Lancet (1969) 3.67
Experimental lepromatous leprosy. Nature (1967) 3.18
Electron-transparent zone of mycobacteria may be a defence mechanism. Nature (1970) 3.18
Ammonia inhibits phagosome-lysosome fusion in macrophages. Nature (1980) 2.89
Agent transmissible from Crohn's disease tissue. Lancet (1970) 2.89
Efficacy and applicability of mass B. C.G. vaccination in tuberculosis control. Br Med J (1967) 2.84
Histological classification and the immunological spectrum of leprosy. Bull World Health Organ (1974) 2.70
Enhanced susceptibility of thymectomized and irradiated mice to infection with Mycobacterium leprae. Nature (1966) 2.63
Significance of variations within the lepromatous group. Lepr Rev (1969) 2.59
Interference with normal phagosome-lysosome fusion in macrophages, using ingested yeast cells and suramin. Nature (1975) 2.58
Reactions in leprosy. Lepr Rev (1969) 2.51
Potentiation by silica of the growth of Mycobacterium tuberculosis in macrophage cultures. Br J Exp Pathol (1968) 2.48
Strain virulence and the lysosomal response in macrophages infected with Mycobacterium tuberculosis. Infect Immun (1974) 2.43
Course and prognosis of sarcoidosis around the world. Am J Med (1974) 2.41
Mycobacterium tuberculosis in macrophages: effect of certain surfactants and other membrane-active compounds. Science (1968) 2.39
A worldwide review of sarcoidosis. Ann N Y Acad Sci (1976) 2.10
Lymphocyte transformation test in leprosy; correlation of the response with inflammation of lesions. Clin Exp Immunol (1976) 2.08
A transmissible agent from sarcoid tissue. Lancet (1969) 2.02
Enhancing effect of antilymphocytic serum on mycobacterial infections in mice. Nature (1968) 1.97
Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis. Clin Exp Immunol (1983) 1.95
Mycobacteria and lysosomes: a paradox. Nature (1969) 1.95
Manipulations of the phagosome-lysosome fusion response in cultured macrophages. Enhancement of fusion by chloroquine and other amines. Exp Cell Res (1978) 1.91
Preliminary taxonomic studies on the leprosy bacillus. Br J Exp Pathol (1975) 1.83
Chemotherapy of Tuberculosis-Part II. Br Med J (1946) 1.81
Serum antibodies and jejunal histology in giardiasis associated with malabsorption. J Clin Pathol (1976) 1.79
Immune responses in mice with murine leprosy. Clin Exp Immunol (1970) 1.79
Sarcoidosis, another disease associated with serologic evidence for herpes-like virus infection. N Engl J Med (1970) 1.78
Biology of the mycobacterioses. Experimental models for studying leprosy. Ann N Y Acad Sci (1968) 1.78
Mycobacterium ulcerans infection. Clinical and bacteriological study of the first cases recognized in South East Asia. Br J Dermatol (1966) 1.77
The nasal dicharge in leprosy: clinical and bacteriological aspects. Lepr Rev (1974) 1.76
Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet (1994) 1.73
The nature of the electron-transparent zone that surrounds Mycobacterium lepraemurium inside host cells. J Gen Microbiol (1973) 1.67
The use of histopathology in leprosy diagnosis and research. Lepr Rev (1989) 1.61
Acid-fast bacilli in the fingers of long-treated lepromatous patients. Lepr Rev (1976) 1.60
Description of sarcoidosis: Report of the Subcommittee on Classification and Definition. Ann N Y Acad Sci (1976) 1.56
Phytohaemagglutinin-induced lymphocyte transformation in leprosy. Clin Exp Immunol (1971) 1.54
Site of action of a polyanion inhibitor of phagosome-lysosome fusion in cultured macrophages. Exp Cell Res (1980) 1.54
INTRAVITREOUS STREPTOMYCIN: ITS TOXICITY AND DIFFUSION. Br J Ophthalmol (1948) 1.53
Recent bacteriologic, immunologic and pathologic studies on experimental human leprosy in the mouse foot pad. Int J Lepr (1966) 1.53
Childhood sarcoidosis--a study of 18 patients. N Engl J Med (1968) 1.51
Sarcoidosis: clinical features and management. Med Clin North Am (1967) 1.48
Human Contagion and Tuberculous Infection in Childhood. Arch Dis Child (1930) 1.47
A logarithmic index of bacilli in biopsies. I. Method. Int J Lepr Other Mycobact Dis (1967) 1.47
Positive Mitsuda lepromin reactions in long-term treated lepromatous leprosy. Lepr Rev (1990) 1.44
Sarcoidosis of the pleura. Ann Intern Med (1974) 1.44
Experimental and clinical studies on rifampicin in treatment of leprosy. Br Med J (1970) 1.43
Surface markers on lymphocytes and cells of the mononuclear phagocyte series in skin sections in leprosy. J Pathol (1978) 1.42
Some immunologic aspects of leprosy. Am Rev Respir Dis (1965) 1.41
Urine tests to monitor the self-administration of dapsone by leprosy patients. Am J Trop Med Hyg (1974) 1.39
Chemical inhibitors of phagosome-lysosome fusion in cultured macrophages also inhibit saltatory lysosomal movements. A combined microscopic and computer study. J Exp Med (1983) 1.39
Tuberculoid relapse in lepromatous leprosy. Lepr Rev (1990) 1.38
Giardiasis: clinical and therapeutic aspects. Gut (1977) 1.37
The arthritis of sarcoidosis. Arthritis Rheum (1969) 1.36
Site of multiplication of human leprosy bacilli inoculated into the foot-pads of mice. Nature (1965) 1.35
A logarithmic index of bacilli in biopsies. 2. Evaluation. Int J Lepr Other Mycobact Dis (1967) 1.32
Muscle involvement in sarcoidosis. Asymptomatic, myositis, and myopathy. Arch Neurol (1969) 1.31
Transmissible agents from human sarcoid and Crohn's disease tissues. Lancet (1976) 1.30
The effect of inhibitors and enhancers of phagosome--lysosome fusion in cultured macrophages on the phagosome membranes of ingested yeasts. Exp Cell Res (1979) 1.30
Use of a detergent-acid mixture to rupture tissue culture cells. Nature (1967) 1.29
Fate of Mycobacterium leprae in macrophages of patients with lepromatous or tuberculoid leprosy. Int J Lepr Other Mycobact Dis (1971) 1.28
The evolution of the lesion in cutaneous leishmaniasis. J Pathol (1983) 1.28
Lepromin and Kveim antigen reactivity in man, and their relation to tuberculin reactivity. Br Med Bull (1967) 1.27
Is there Kveim responsiveness in Crohn's disease? Lancet (1971) 1.26
Phytohemagglutinin skin test: a possible in vivo measure of cell-mediated immunity. J Pediatr (1972) 1.24
The evaluation of drugs for leprosy: bacteriological considerations. Trans R Soc Trop Med Hyg (1967) 1.23
Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy. Int J Lepr Other Mycobact Dis (1967) 1.23
Early controlled clinical trials. BMJ (1996) 1.23
New prospects for the study of leprosy in the laboratory. Bull World Health Organ (1969) 1.22
A histological classification of cutaneous leishmaniasis and its geographical expression. Trans R Soc Trop Med Hyg (1980) 1.22
Human leprosy in normal mice. Br Med J (1969) 1.22
AIDS and leprosy. Lepr Rev (1988) 1.21
Sulphone resistance in leprosy. A review of one hundred proven clinical cases. Lancet (1975) 1.20
The pathogenesis of the early skin lesion in leprosy. J Pathol (1973) 1.20
An evaluation of the ELISA for schistosomiasis in a hospital population. Trans R Soc Trop Med Hyg (1986) 1.18
Antigenic heterogeneity in patients with reactions in borderline leprosy. Br Med J (1975) 1.18
Studies on sulfone resistance in leprosy. I. Detection of cases. Int J Lepr Other Mycobact Dis (1967) 1.18
Induction of delayed-type hypersensitivity to Mycobacterium leprae in healthy individuals. Clin Exp Immunol (1981) 1.18
Evidence for prevention of borderline leprosy reactions by dapsone. Lancet (1976) 1.15